Dr Srour on the Safety and Efficacy of the Allogeneic CAR T-Cell Therapy CTX130 in Advanced ccRCC
Samer A. Srour, MB ChB, MS, discusses efficacy and safety data for the allogeneic CAR T-cell therapy CTX130 in advanced clear cell renal cell carcinoma.
United States Samera Srour University Of Texas Md Anderson Cancer Center Department Of Stem Cell Transplantation Division Of Cancer Medicine Stem Cell Transplantation
Source: onclive.com